Physician profile
David Barton Doyle
NPI 1326499849
$1,533.94
in general payments reported to CMS, 2019-2025
12 companies · $313 in 2025
The $313 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $120 · 2021: $318 · 2022: $167 · 2023: $125 · 2024: $247 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518 · Travel and Lodging: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.66 |
| Travel and Lodging | $167.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $474.85 | 2020-2025 | Fluent Fluid Management System, Omni Hysteroscope, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $260.94 | 2021 | |
| Intuitive Surgical, INC. | $167.30 | 2025 | |
| Organon LLC | $135.81 | 2024-2025 | Jada System |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Myfembree |
| Lsi Solutions INC | $123.40 | 2019 | |
| Asensus Surgical, INC. | $120.83 | 2019 | |
| Welch Allyn | $35.56 | 2021 | |
| Astellas Pharma US INC | $30.00 | 2024 | Veozah |
| Organogenesis INC. | $24.53 | 2025 | Cygnus Matrix |
| Avanos Medical | $21.82 | 2021 | |
| Baxter Healthcare | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.